Home › Breast Cancer › NCT07553572

Remote Monitoring and Symptom Management Digital Application

Pilot Randomized Controlled Trial of a Remote Monitoring and Symptom Management Intervention (ASSIST) Among Patients Receiving Systemic Therapy

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Age 18 years or older
2. Ability to understand English
3. About to begin definitive systemic treatment (or within 4 weeks of beginning treatment) based upon the oncology treatment intent form for a new diagnosis of breast cancer, colorectal cancer, or lymphoma.
4. Expected treatment duration of at least 12 weeks
5. Own or willing to receive a smartphone

Exclusion Criteria:

1. Cognitive impairment that would interfere with ability to use smartphone application (as assessed by their attending physician)
2. Visual or motor impairment that would prevent smartphone use
3. Expected survival less than 3 months

About the study

The goal of this clinical trial is to learn if an artificial intelligence phone application called ASSIST can help patients receiving cancer treatment.

The main question\[s\] it aims to answer are:

Is ASSIST feasible for patients (meaning can it be used by patients)? Is ASSIST acceptable to patients (meaning do patients like it)?

Researchers will compare the ASSIST phone application to see how it compares to usual clinical care.

Participants on the ASSIST arm will use the ASSIST phone application for 12 weeks, and participants in both groups will complete surveys.

What is being tested

• ASSIST phone application (other)

Sponsor: Patrick C. Johnson, MD · Participants: 60 · Started: Apr 14, 2026

Contact the study team

• Patrick C Johnson, MD · Phone: 6177244000

Official record on ClinicalTrials.gov — NCT07553572

Locations in the U.S.

Conditions

• Breast Cancer
• Metastatic Cancer
• Lymphoma
• Colorectal Cancer

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.